entertainment -WSS

entertainment

author：hotspot 2025-09-02 09:33:30 - browse：5866

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Digital health funding stays low as a new reality sets in

WSS

After half a century, Israel moves to evict squatter from his cave home on the beach

Be careful with at

Be careful with at

Indictment alleges Trump's ex

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

China sends large group of warplanes, navy ships towards Taiwan in forceful display

entertainment

entertainment

focus

Dobbs anniversary: the lost opportunity of abortion as health care

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Wildfire smoke exposes gaps in outdoor worker protections

How are insurers handling Leqembi and related scans?

Sports medicine is finally prioritizing gender equality

Companies helping big Covid

Hollywood unions extend contract negotiations for actors

BMS, looking to build heart drug business, turns to AI for diagnosis

Apple is now the first public company to be valued at $3 trillion

Indictment alleges Trump's ex

entertainment

Inflation cooled significantly in June, bringing price hikes close to normal levels

After Optum profits sink, UnitedHealth makes changes

After Optum profits sink, UnitedHealth makes changes

Indictment alleges Trump's ex

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

leisure time

focus

entertainment

entertainment